Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Regeneron Pharmaceuticals, Inc. Transaction History
Fjarde Ap Fonden (The Fourth Swedish National Pensionfund)
- $8.86 Billion
- Q2 2024
A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 29,252 shares of REGN stock, worth $24.2 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
29,252Holding current value
$24.2 Million% of portfolio
0.35%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,483Shares Held
85.7MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.45 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$6.86 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.01 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.84 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $88.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...